Advertisement FDA reinspects Perrigo Allegan facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA reinspects Perrigo Allegan facility

The Detroit Office of the Food and Drug Administration (FDA) has reinspected Perrigo's Allegan facility as a follow-up to the warning letter the company has received in 30 April 2010.

Perrigo is a global healthcare supplier engaged in developing, manufacturing and distributing OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.

The company’s primary markets and locations of manufacturing facilities are the US, Israel, Mexico and the UK.